Fuente, J. D. L., Baronciani, D., Fekom, M., Dalissier, A., Zecca, M., Locatelli, F., Nasa, G. L., Cerretti, R., Ghafoor, T., Visani, G., Ozdogu, H., Ciceri, F., Mousavi, A., Bremathas, S., Corbacioglu, S., Angelucci, E. (2025). The need for a subsequent HCT is a late & continuous risk and with significant impact in overall survival in haemoaglobinopathies: Real-world data from 2000–2022. an analysis of the european society for blood and marrow transplantation (EBMT) hemoglobinopathy working party.. Blood. https://doi.org/10.1182/blood-2025-178